Amgen pledges $1.5bn for CytomX preclinical cancer drugs | Boulder Peptide Symposium

September 15-18, 2025

LIVE, In Person at the St. Julien Hotel in Boulder, Colorado
The only conference focused solely on the pharmaceutical development of peptide therapeutics.

Amgen pledges $1.5bn for CytomX preclinical cancer drugs

Amgen pledges $1.5bn for CytomX preclinical cancer drugs

... which are designed to direct immune T cells to cancer cells, while incorporating a masking peptide to reduce binding to healthy tissues and prevent ...


s2Member®
loading...